# Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

> **NCT00432341** · PHASE4 · TERMINATED · sponsor: **Allergan** · enrollment: 54 (actual)

## Conditions studied

- Spasmodic Torticollis

## Interventions

- **BIOLOGICAL:** botulinum toxin type A
- **BIOLOGICAL:** botulinum toxin type A

## Key facts

- **NCT ID:** NCT00432341
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-06
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** Study was terminated early due to difficulties with patient recruitment
- **Last updated:** 2011-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432341, "Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00432341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*